Dexilant
Dexilant

0.94
A clinical formulation indicated for Digestive Health. Promotes acid reduction within the stomach to assist with the management of gastrointestinal discomfort and tissue irritation.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Dexlansoprazole
Reference Brand
Dexlansoprazole
Product Origin
Generic Alternative
Reference Manufacturer
Takeda Pharmaceutical
Product Form
Delayed-release Capsule
Regulatory Classification
Rx
Primary Category
Digestive Health
Product Category
Proton Pump Inhibitor (PPI)
Pharmacological Class
Antacid
Off-Label Uses
Manufacturer Description
A dual-release PPI utilized to manage acid reflux symptoms and intended to alleviate heartburn to support healing of the esophagus.
Mechanism of Action
It uses a dual delayed-release system to provide two peaks of acid suppression. It irreversibly inhibits the proton pump in stomach cells, reducing acid.
Route of Administration
Oral
Onset Time
1–3 hours (full effect 4 days)
Duration
24 hours
Contraindications
Use of rilpivirine, Severe liver disease (dosage adjust), Allergy to PPIs
Severe Adverse Events
Clostridium difficile diarrhea, Vitamin B12 deficiency (long-term), Bone fractures, Low magnesium
Common Side Effects
Diarrhea, Abdominal pain, Nausea
Uncommon Side Effects
Flatulence, Upper respiratory infection, Vomiting, Common cold symptoms
Drug Interactions
Rilpivirine, Warfarin, Methotrexate, Digoxin, Clopidogrel
Pregnancy Safety Warnings
Use only if potential benefit justifies the risk.
Age Restrictions
Approved for patients 12 years and older.
Storage Guidelines
Store at room temperature in a dry place.
Related Products
Esomeprazole, Pantoprazole, Lansoprazole
Information for Dexilant is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories